Prescription, dispensing, and regulation of psychoactive anorexigenic drugs in Belo Horizonte, Minas Gerais, Brazil

Departamento de Farmácia Social, Universidade Federal de Minas Gerais, Belo Horizonte, Brasil.
Cadernos de saúde pública / Ministério da Saúde, Fundação Oswaldo Cruz, Escola Nacional de Saúde Pública (Impact Factor: 0.98). 09/2008; 24(8):1763-72.
Source: PubMed


This retrospective study in Belo Horizonte, Minas Gerais, Brazil, aimed to provide indicators on the sale and consumption of anorexigenic substances. During the first stage, 2,906 of 168,237 prescriptions received by pharmacies in 2003 were analyzed, showing low quality of prescriptions. Projected consumption in defined daily doses was 19.75 DDD/1,000 inhabitants/day in 2003. Fenproporex (59.8%) was the most widely consumed drug. One pharmacy was responsible for 39.8% of the pharmaceutical sales. During the second stage, 14,554 sales records from this "blockbuster" pharmacy were analyzed, from April to August 2005; 9.2% of sales were for anorexigenic products, 91.8% of which prescribed in association with another substance. The data suggest irrational use of anorexigenic drugs by these consumers and highlight the need for proper regulation of these products. It is important to understand both the role of pharmacies in this regulation and that of physicians in the rational use of these substances.

Download full-text


Available from: Francisco de Assis Acurcio, Jun 24, 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A study was conducted on 22,158 special B prescriptions (notificações B) containing amphetamine-type anorectic drugs or benzodiazepines, obtained from compounding pharmacies or drugstores located in the city of Natal, RN, Brazil. The data obtained were compared with those from other Brazilian cities. Results showed that compounding pharmacies dispensed 85.4% of the prescriptions, indicating that these pharmacies filled out nearly 10 times more of these prescriptions than did the drugstores. The majority (83.5%) of B prescriptions issued for the compounding pharmacies were for women, where the female/male patient ratio ranged from 7.1/1.0 for mazindol to 10.3/1.0 for amfepramone. Similar results were obtained for the benzodiazepines with ratios of 1.9/1.0 for clonazepam to 15.6/1.0 for oxazepam. Omissions and mistakes were present in the B prescriptions, including missing information about the patient (in 49.6% of the documents) or about the pharmacies or drugstores (50.4%). There were cases where the name and/or CRM of the physician was lacking. It was noted that one medical doctor made out 1855 B prescriptions within one year. The same patient's name appeared on 138 prescriptions, and the same RG (identification card number) was present in 125 others. Comparison of Natal's data with those of several other Brazilian cities disclosed a striking similarity throughout Brazil, from Pelotas - Rio Grande do Sul State to Belem-Para State, revealing a practically identical medical/pharmaceutical behavior. This pattern of prescription/dispensation of amphetamine-type substances mostly to women for weight loss is therefore for cosmetic reasons. Consequently, there is an urgent need for an ethical review of this behavior.
    Full-text · Article · Jun 2010 · Brazilian Journal of Pharmaceutical Science
  • [Show abstract] [Hide abstract]
    ABSTRACT: A prescription is a document that should enable a dialogue between prescriber, dispenser and user, conducive to the correct and rational use of medicines. To that end, the prescription must fulfill certain requirements. The objective of this study was to check compliance with some aspects of the law in prescriptions for medicines used to treat obesity, dispensed in the city of Ijuí, and to discuss the repercussions on the dispensing and use of these medicines. We analyzed 80 prescriptions, in which the most frequently omitted items were the user's address (95%), prescription of medication by Brazilian Common Name (BCN) (80%), pharmaceutical form (67%), dosage (13.75%) and date of issue (15%). Of particular concern is the absence of the dosage, which could lead to the administration of an inappropriate dose of the medicine, triggering adverse reactions or diminishing the expected effect. The results point to a set of risks related to the medical treatment of obesity, indicating a need to reassess the conduct of all the participants in the process: users, prescribers, dispensers and regulatory bodies. The study highlights the importance of continuing education of prescribers and dispensers in the light of ethical issues that should guide the prescribing and dispensing of medicines, especially those subject to special control, which should be used to support a therapy that goes beyond medication.
    No preview · Article · Jan 2011 · Revista de Ciencias Farmaceuticas Basica e Aplicada
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The scope of this study was to understand the motives that lead adult women to use appetite inhibitors and to establish, from a gender perspective, how these women relate to their own bodies. It was structured around the principles of qualitative research, and the methods of data collection were semi-structured interviews and direct observation. The informants were six women who used appetite inhibitors. The results indicated that images, publicity and social networks contribute significantly to the creation of new standards of physical appearance as well as lifestyles, which establish appearance (a slim body) and a happy marriage as the desired model. The slim body is represented as something able to alter the temperament of the individual, in other words a fat person is an unhappy person and a slim person is a happy person. The study shows that it is in the body per se that the social role destined for women is produced and reproduced.
    Full-text · Article · May 2011 · Ciencia & saude coletiva
Show more